Durham, NCNCT06859762Now EnrollingIRB Ready

Advanced Solid Tumor Clinical Trial in Durham, NC

Access cutting-edge advanced solid tumor treatment through this clinical trial at a research site in Durham. Study-provided care at no cost to qualified participants.

Sponsored by MediLink Therapeutics (Suzhou) Co., Ltd.

Quick Self-Assessment

See if you qualify for this Durham location

Preparing your pre-screening questions…

Expert Care in Durham

Access advanced solid tumor specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related advanced solid tumor treatment provided free

Apply for This Durham Location

Check if you qualify for this advanced solid tumor clinical trial in Durham, NC

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Durham

    Convenient for NC residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Durham site if eligible
  4. 4Begin participation

About This Advanced Solid Tumor Study in Durham

A Phase 1 First-in-Human study of YL217 in Patients with Advanced Solid Tumors

Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Who Can Participate

Inclusion Criteria

Informed of the study before the start of the study and voluntarily sign their name and date in the ICF
Able and willing to comply with protocol visits and procedures
Age≥ 18 years
ECOG PS of 0 or 1
Tumor types as below: For Part 1 and Part 2: Pathologically confirmed diagnosis of an advanced solid tumor. For Part 3 (Histologically or cytologically confirmed diagnosis+ locally advanced unresectable or metastatic disease)
Adequate organ and bone marrow function.
Have at least 1 extracranial measurable tumor lesion.
Adequate archival formalin-fixed paraffin embedded （FFPE） tissue from prior biopsy.

Exclusion Criteria

Prior treatment with an agent targeting CDH17
Prior discontinuation of a topoisomerase I inhibitor due to treatment-related toxicities.
Have received an ADC consisting of a topoisomerase I inhibitor.
Concurrent enrollment in another clinical study, unless it is an observational clinical study.
Inadequate washout period for prior anticancer treatment before the first dose of study drug
Undergone major surgery within 4 weeks before the first dose of study drug or expect major surgery during the study.
Received long term systemic steroids or other immunosuppressive therapy within 2 weeks before the first dose of study drug.
Received any live vaccine within 4 weeks before the first dose of study drug or intend to receive a live vaccine during the study.
Diagnosis or evidence of spinal cord compression or leptomeningeal carcinomatosis.
Uncontrolled or clinically significant cardiovascular and cerebrovascular diseases.
A history of non-infectious interstitial lung disease (ILD)/pneumonitis that requires steroids, current active ILD/pneumonitis.
Have clinically severe pulmonary compromise resulting from intercurrent pulmonary illnesses.
Uncontrolled third-space fluid that requires repeated drainage.
Digestive system disease that may cause bleeding, perforation, jaundice, gastrointestinal obstruction.
An active tuberculosis based on medical history.
Known human immunodeficiency virus (HIV) infection.
Active hepatitis C infection.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Durham?

Yes, this clinical trial (NCT06859762) has an active research site in Durham, NC that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Advanced Solid Tumor Treatment Options in Durham, NC

If you're searching for advanced solid tumor treatment options in Durham, NC, this clinical trial (NCT06859762) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Durham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced advanced solid tumor specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all advanced solid tumor clinical trials near you to find additional studies recruiting in your area.

More Advanced Solid Tumors Trials in Durham, NC

See all advanced solid tumors clinical trials recruiting in Durham — not just this study.

Browse Advanced Solid Tumors Trials in Durham →

Browse More Trials by Condition

Advanced Solid Tumors TrialsAlzheimers Disease TrialsAtopic Dermatitis TrialsErectile Dysfunction TrialsAll Conditions →

Ready to Join in Durham?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Durham, NC